Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 69.6B | 84.5B | 85.8B | 80.4B |
| Cost of revenue | 45.9B | 54.8B | 55.6B | 54.7B |
| Gross profit | 23.7B | 29.6B | 30.3B | 25.8B |
| Operating expense | ||||
| Research & development | 241M | 987M | 761M | 705M |
| Selling general and admin | 2.8B | -5.2B | 6.6B | -1.8B |
| Other operating expenses | 4.0B | 5.3B | 4.1B | 4.6B |
| Operating income | 16.7B | 20.7B | 22.8B | 18.4B |
| Non operating interest income | ||||
| Income | 627M | 622M | 689M | 750M |
| Expense | 661M | 559M | 2.2B | -699M |
| Other income expense | — | — | — | — |
| Pretax income | 18.0B | 19.5B | 23.6B | 20.0B |
| Tax provision | 3.3B | 4.5B | 4.5B | 4.0B |
| Net income | 14.7B | 15.1B | 19.2B | 16.0B |
| Basic EPS | 0.6 | — | — | — |
| Diluted EPS | 0.6 | — | — | — |
| Basic average shares | 19.9B | — | — | — |
| Diluted average shares | 19.9B | — | — | — |
| EBITDA | 18.6B | 20.8B | 25.7B | 19.3B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -2.7B | -2.5B | -2.6B | -2.4B |
| Preferred stock dividends | 0 | 0 | 0 | 0 |